Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 36.59 M33.36 M47.67 M41.96 M42.46 M 165.45 M Research & development 55.46 M47.2 M54.25 M51.69 M53.16 M 206.3 M Operating income -46.09 M-24.61 M-41.29 M-14.89 M-17.21 M -98 M Non-Operating Income, Total -2.91 M-6.09 M-2.1 M-2.91 M-1.44 M -12.54 M Interest expense, net of interest capitalized 2.5 M2.51 M2.65 M2.39 M2.2 M 9.75 M Non-Operating Income, excl. Interest Expenses -1.64 M-1.7 M-1.77 M-1.56 M-1.56 M -6.59 M Unusual income/expense -1.27 M-4.39 M-324 K-1.35 M121 K -5.94 M Pretax income -49 M-30.7 M-43.39 M-17.8 M-18.65 M -110.54 M Equity in earnings ————— — Taxes 711 K-4.12 M2.1 M-2.91 M26.48 M 21.56 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -49.71 M-26.59 M-45.48 M-14.9 M-45.14 M -132.1 M Discontinued operations ————— — Net income -49.71 M-26.59 M-45.48 M-14.9 M-45.14 M -132.1 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -49.71 M-26.59 M-45.48 M-14.9 M-45.14 M -132.1 M Basic earnings per share (Basic EPS) -0.58-0.31-0.52-0.17-0.52 -1.52 Diluted earnings per share (Diluted EPS) -0.58-0.31-0.52-0.17-0.52 -1.52 Average basic shares outstanding 85.27 M86.63 M87.19 M86.59 M87.59 M — Diluted shares outstanding 85.27 M86.63 M87.19 M86.59 M87.59 M — EBITDA -34.95 M-13.4 M-30.45 M-4.1 M-6.27 M -54.22 M EBIT -46.09 M-24.61 M-41.29 M-14.89 M-17.21 M -98 M Cost of revenue 42.1 M47.29 M54.56 M57.88 M58.3 M 218.03 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 11.15 M11.22 M10.84 M10.79 M10.94 M 43.78 M